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Abstract: The aim of this study was to determine the level of knowledge about the intravenous contrast materials (IVCMs) and their
risks in patients in an Anatolian city. The study included 156 outpatients who applied for radiographic studies requiring the use of
IVCMs. The data were obtained by face-to-face interviews before the radiographic examination. The questionnaire was designed
specifically for this study and the respondent was given a total score of 100 points for all correct answers. Patients’ information
about the IVCMs, their risks, and their role in the diagnosis of some diseases were investigated with this survey. ANOVA, t-test and
chi-square test were used for statistical analysis. Most of the patients were found not to have sufficient information about the
potential risks and side effects of IVCMs. The mean score was 54.80 ± 12.60 (ranging between 20 and 85) out of 100. The patients
who knew about the contrast materials and had higher education levels got higher scores (P = 0.000). Scores were significantly
higher in patients who had had previous procedures with intravenous contrast material injections compared to the others who had
never received contrast materials before (P = 0.021). Although the patients with higher education levels were shown to have more
knowledge about the contrast materials compared to with lower education levels, most of the respondents still were not sufficiently
aware of the risks and side effects of the contrast materials. These results indicate that all patients should be informed about the
side effects and potential risks of IVCM injections before the procedure.
Key Words: Contrast media, informed consent, information management

Introduction
The radiologist is obliged to obtain informed consent
before performing procedures requiring the intravascular
(IV) administration of contrast materials (1). Informed
consent is used both to inform patients about procedures
and to protect physicians from litigation (2-4). It involves
the advantages and disadvantages, risk factors and
potential side effects of intravascular contrast materials
(IVCMs), other alternatives, and the patient’s permission
for IVCM use (2,5-7).
Prior written information concerning the risks
associated with IV injections of contrast material for
diagnostic imaging is rarely given to patients in Turkey.

Previous studies reported that a common reason given
for not obtaining informed consent was that the anxiety
produced by informing the patient would increase the
potential for an adverse reaction (8-10). However, many
recent reports suggested that patients would like to be
informed about the risks associated with IV injections of
contrast materials (3,6,11-14).
IV administration of iodinated contrast materials has
been frequently used for the diagnosis of several diseases,
especially in computerized tomography (CT) and
excretory urography, at many different medical centres
such as university, state and private hospitals, and smallscale diagnostic centers in Turkey, and also in our city,
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Afyon. The purpose of this study was to evaluate the level
of awareness of patients about IVCMs and to discuss the
obligation of obtaining informed consent.

Materials and Methods
Between October 2002 and April 2003, a crosssectional questionnaire survey was carried out in Afyon, a
small city in Anatolia Turkey. The study included 156
cooperative outpatients (62 female and 94 male; mean
age 43.39 ± 12.53 years; age range 18-76 years) who
applied for radiographic studies, either CT or excretory
urography, requiring the use of IVCMs. Nonionic contrast
material was used in both examinations. In total, 44
patients were physically unable to complete the
questionnaire. When the patients arrived at the radiology
department, they were asked by our technicians to read
and sign the questionnaire together. Patients were not
allowed to use any materials or sources during the test.
The questionnaire contained 16 questions, having a
combination of true-false and multiple choice answers
and 5 points were given for each correct answer. Each
patient was scored over a total of 100 points. The
following information was evaluated in the questionnaire:

demographic data (age, education and employment),
patients’ knowledge about the IVCMs, and their role in
the diagnosis of some diseases and their risk factors and
side effects (see Appendix). This study protocol was
approved by our institutional Ethics Committee and
informed consent was obtained from all participants.
Statistical Analysis
Statistical analysis was performed using SPSS version
10.0. Among the parametric tests, t-test for 2-group
comparison and ANOVA for 3-group comparison were
used. For nonparametric analysis, the chi-square test was
applied. All results were expressed as means ± SD. A P
value of < 0.05 was considered to indicate a statistically
significant difference.

Results
Sociodemographic characteristics of the participants
and their knowledge about IVCMs are shown in Table 1.
Fifty-nine participants (37.8%) had completed primary
school and 53 participants (34.0%) were unemployed.
Sixty-six participants (42.3%) had no idea about IVCMs.

Table 1. Patients’ sociodemographics and their own knowledge about IVCMs.
Characteristics

No. of Patients
(n = 156)

%

Sex
Male
Female
Educational level
Illiterate
Not school educated, but literate
Primary (0-5 years)
Secondary (6-8 years)
High (9-11 years)
University (12-17 years)
Employment
Unemployed
Employed
Retired
Knowledge about IVCMs
More than sufficient
Sufficient
Partially sufficient
Insufficient
No idea
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94
62

60.3
39.7

7
11
59
24
33
22

4.5
7.1
37.8
15.4
21.2
14.1

53
67
36

34.0
42.9
23.1

8
8
20
54
66

5.1
5.1
12.8
34.6
42.3
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We also planned to check the awareness of
participants about radiation. Surprisingly, 126
participants (80.8%) correctly answered the question
about the energy type used in their examination.
In 151 of the patients (96.8%), no history of allergy
to any materials such as foods or drugs was obtained. A
previous history of IVCM injection was valid for 62
patients (39.7%). Of these, 26 patients (17%) had had
IV contrast-enhanced CT and 42 patients (27%) had had
IV excretory urography before.
There were 2 questions about the indications for
using IVCMs. Most of the patients correctly answered
both questions. Of these, 130 patients (83.3%) knew
that these materials were used for better visualization of
some tissues and 141 patients (90.4%) were aware of
their importance for diagnosis. These questions had 2
responses (true or false), and so the probability of giving
the correct answer was 50%. However, a much greater
proportion answered these questions correctly.
Information about patients’ knowledge of risk factors
and serious adverse reactions to IVCMs is given in Table
2. Of all the patients, 93 (59.6%) thought that IVCMs
could be administrated to anyone safely. While 99
patients (63.5%) were conscious these materials should

not be given to patients with a history of allergic reaction,
the risks of IVCM application in patients with kidney
disease and asthma were not known by 119 patients
(76.3%) and 123 patients (78.8%), respectively. Most of
the patients were shown to have insufficient information
about potential serious reactions to IVCM administration.
One hundred twenty-four participants (79.5%) knew
that IVCMs could cause insignificant side effects such as
nausea, vomiting or a rash, while 106 of them (67.9%)
knew that serious adverse reactions, although rare, could
occur. However, the responses to the question about the
risk of death attributed to the use of IVCMs, proved a
lack of awareness among the participants. The question
had 2 responses, and so the probability of giving the
correct answer was 50%. Ninety-two patients (59.0%)
gave the wrong answer to this question. They did not
know that IVCM use could lead to death, although very
rarely.
When the scoring was done for each correct answer,
the mean score was 54.80 ± 12.60 (range 20-85).
Comparisons of responses of each group according to the
scores are shown in Table 3. As expected, the patients
who had previous information about IVCMs got higher
scores (P = 0.000). Scores were significantly higher in

Table 2. Knowledge about risk factors and serious adverse reactions against IVCMs.
Characteristics

The risk factors associated with IVCM are
cancer
cardiovascular disease
history of allergy
tuberculosis
asthma
renal disease
previous history of IVCM administration without
any reaction
The serious side effects IVCM are
shortness of breath
loss of consciousness
increased heart rate
diarrhea
itching
convulsion

No. of Patients
(n = 156)

%

98
70
99
142
33
37

62.8
44.9
63.5
91.0
21.2
23.7

135

86.5

73
56
56
61
65
31

46.8
35.9
35.9
39.1
41.7
19.9

Note.— Values are numbers of correct responses.
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Table 3. Comparison of each group’s responses according to scores.
(First group) vs (second group)

First group score (n)
(mean ± SD)

Second group score (n)
(mean ± SD)

P Value*

(Male) vs. (female)

56.32 ± 13.30(94)

52.50 ± 11.15(62)

0.054

(Primary school and lower) vs. (higher)

50.58 ± 10.97 (77)

58.92 ± 12.77 (79)

0.000

(Previous history of IVCM administration) vs. (not)

57.66 ± 12.66 (62)

52.92 ± 12.25 (94)

0.021

(Knowledge about IVCM more to partially sufficient)
vs. (not sufficient and no idea)

65.83 ± 12.62 (36)

51.50 ± 10.58 (120)

0.000

* Compared by using the t-test

patients who gave a history of procedures with IVCM
injections compared to those who did not (P = 0.021).
Not surprisingly, education level was also an important
factor in having sufficient knowledge about IVCM (P =
0.000). Although the difference was statistically
insignificant, men seemed to know more about IVCM
than did women (P = 0.054) and the unemployed group
got lower scores compared to patients with different
occupations (P = 0.001). The important point supporting
the last 2 results was that the unemployed group was
composed of only women, because all of the men in the
study population were employed. Chi-square analysis
revealed that the application ratios of IVCMs to both men
and women before were almost equal (P = 0.830) and
there was a significant difference in the level of education
between the 2 genders (P = 0.000), i.e. women were
found to have lower education levels.

Discussion
As Hippocrates advised ‘Primum non nocere’, a
physician’s primary duty is to do what is beneficial for the
patient and not to cause unnecessary harm (11). In our
daily practice, the fact that the probability of a serious or
life-threatening reaction against IVCMs is very low on
average leads many to think that written consent is not
required (6). This point is debatable when it is considered
from the view of patient’s right to be aware of the
application’s risks.
In fact, we observed that most of the patients knew
that contrast materials were used for better visualization
of tissues by enhancing them and for facilitating the
diagnosis of most diseases. However, they that IVCMs
could be safely given to everybody. According to our
110

survey, they did not have sufficient information about the
risk factors and potential side effects of IVCMs (Table 2).
Several investigators have reported that the informed
consent process may increase anxiety and the prevalence
of adverse reactions among patients informed of the risks
associated with IVCM usage (8-10). Studies from Turkey
on this issue have given different results. While Bozkurt
et al. (15) found that anxiety levels increase in informed
patients, another study, by Sakan et al. (16), showed no
change in the anxiety level of informed patients. Although
we did not evaluate the anxiety levels of patients after
they received information, we observed that the
participants became anxious when reading the questions
about the serious side effects of IVCMs and death. At the
end of the survey, the ratio of correct answers of the
participants about potential serious side effects and death
was 19.9%-46.8%. In other words, patients did not
expect serious risks like death as a consequence of such a
simple procedure required for the diagnosis of a disease.
However, in some other studies, different results have
been obtained. Regardless of the severity or low
frequency of the risks of IVCMs, the vast majority of
patients demanded and accepted information before
IVCM administration about the risk factors and side
effects (3,6,11-14). It was found that informing patients
of the risks associated with IVCMs did not increase
anxiety or the frequency of adverse reactions. It was
suggested that the use of therapeutic privilege in not
obtaining informed consent to avoid an increase in
anxiety-induced adverse reactions against IVCMs was not
justified (11).
In our study, the mean score showing knowledge
about IVCMs was better than in previous studies (4,17),
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which used informed consent before IVCM
administration. However, Neptune et al. (4) reported that
the average patient was still inadequately informed. From
this country, Belet et al. (17) suggested giving
information about the contrast material before the
examination, since their study population had a lower
knowledge about IVCMs and their side effects.
Belet et al. (17) also found no significant differences
related to sex, age, education level or previous contrast
material administration. In contrast to previous similar
studies (4,9,10), our results suggested that women had
lower knowledge scores than did men although the
difference was statistically insignificant (Table 3).
Furthermore, the unemployed group, composed of only
women, had lower knowledge scores. Additionally,
women had a lower level of education than did men. All
these findings pointed out the necessity of giving more
attention and care to educating and informing women.
The higher scores of men can be explained by their having
a higher level of education and forming an employed and
freely communicating and interacting group.
Not surprisingly, patients who had undergone
previous procedures with IVCM injections answered more
questions correctly than those who had not. It was not
unexpected that patients with higher education levels also
had a higher baseline knowledge (Table 3).
It is the patient’s natural right to be informed of all
potential risks caused by the procedure applied to him or
her (11,14). However, this is usually a time-consuming
process. Of the information provided to the patients, to
what extent do they retain it and how much of it is
sufficient? In a recent study, answers to these questions
were sought. No information was given to a group of
patients and a generic permission form was signed by
each of them. It took a total of 51 min of the
technologist’s time. If a physician were to be counselled
for detailed information, almost 6 h would be required
each day (6). Although informing each patient leads to
deterioration of the workflow of technologists and
radiologists in radiology departments, which are always
too busy, this service should be supported. Written or
illustrated brochures informing people can be distributed

to patients during the waiting period before all contrastenhanced and non-enhanced radiological procedures.
Supporting our results, patients having a higher level
of education will both understand the information given
to them more easily and will be informed repeatedly each
time they undergo a new procedure. Consequently, each
patient will be better informed and more conscious
compared to those who have never been exposed to
IVCMs. Moreover, for informing much greater
populations, especially those with lower levels of
education, panels designed for people, in particular the
unemployed and those spending most of their time at
home, can be arranged or the media (local written and
oral press: radio, television (soap operas), internet and
newspapers, etc.) can be used.
In conclusion, although patients with higher education
levels and a previous history of IVCM administration were
shown to have more knowledge about IVCM compared to
patients with lower education levels and no previous
experience with IVCMs, most of the attendants still were
not aware of the risks and side effects of IVCMs. These
results indicate that all patients should be informed about
the risk factors and potential adverse reactions of IVCMs
before the procedure. It is the patient’s ethical, legal and
medical right to be aware of the potential side effects of
procedures applied to them.
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APPENDIX: Contrast Material Survey Form
1. Age:
2. Sex:

1) Male

2) Female

3. Employment:

1) Unemployed

2) Civil servant

3) Worker

4) Retired

5) Self-employed

6) Other....................

1) Non-literate

2) Literate

3) Primary school

4) Secondary school

5) High- chool 6) University

4. Level of education:

5. What kind of energy is used in the examination you will undergo?
1) X-ray

2) Ultrasound

3) Radio frequency

6. How much do you feel you know about intravenous contrast materials?
1) More than sufficient

2) Sufficient

4) Insufficient

5) No idea

3) Partially sufficient

7. Do you have any allergic reactions previously against food or drugs?
0) No

1) Yes (List, please).............................................................

8. Have you ever undergone any kind of procedure in which an IVCM was used?
0) No

1) Yes (List, please).............................................................

9. The aim of administration of IVCMs is better visualization of tissues and diseases by enhancing them.
1) True

2) False

10. Contrast materials play an important role in the diagnosis of diseases.
1) True

2) False

11. IVCMs can be administered safely to every patient.
1) True

2) False

12. Of the following, which are at risk from an IVCM injection? (you can mark more than one)
1) Patients with cancer

2) Patients with cardiovascular disease

3) Patients with a history of allergy

4) Patients with tuberculosis

5) Patients with asthma

6) Patients with renal disease

7) Patient who received IVCM previously but had no allergic reaction
13. Contrast materials can cause unimportant side effects such as nausea, vomiting or a rash
1) True

2) False

14. Contrast materials can cause serious side effects, although rarely.
1) True

2) False

15. Which of the following can be a serious side effect of IVCMs? (you can mark more than one)
1) Shortness of breath

2) Loss of consciousness

3) Increased heart rate

4) Diarrhea

5) Itching

6) Convulsion

16. Contrast materials can cause death, although very rarely.
1) True

2) False
Thank you...
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